Mauler F، Hinz V، Augstein KH، Fassbender M، Horváth E (أكتوبر 2003). "Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271". Brain Research. ج. 989 ع. 1: 99–111. DOI:10.1016/s0006-8993(03)03376-6. PMID:14519516. S2CID:20422282.
Mauler F، Mittendorf J، Horváth E، De Vry J (يوليو 2002). "Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties". The Journal of Pharmacology and Experimental Therapeutics. ج. 302 ع. 1: 359–68. DOI:10.1124/jpet.302.1.359. PMID:12065738.
De Vry J، Rüdiger Jentzsch K (ديسمبر 2002). "Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist". European Journal of Pharmacology. ج. 457 ع. 2–3: 147–52. DOI:10.1016/s0014-2999(02)02697-3. PMID:12464360.
Mauler F، Hinz V، Augstein KH، Fassbender M، Horváth E (أكتوبر 2003). "Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271". Brain Research. ج. 989 ع. 1: 99–111. DOI:10.1016/s0006-8993(03)03376-6. PMID:14519516. S2CID:20422282.
Mauler F، Mittendorf J، Horváth E، De Vry J (يوليو 2002). "Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties". The Journal of Pharmacology and Experimental Therapeutics. ج. 302 ع. 1: 359–68. DOI:10.1124/jpet.302.1.359. PMID:12065738.
De Vry J، Rüdiger Jentzsch K (ديسمبر 2002). "Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist". European Journal of Pharmacology. ج. 457 ع. 2–3: 147–52. DOI:10.1016/s0014-2999(02)02697-3. PMID:12464360.